​​​​young investigator award winners

• ​Lukas Tomas, Sweden - A lipid metabolite profile in atherosclerotic plaques associated with increased inflammation and cardiovascular risk
  

• ​Francesca Vinch​i, Germany - Iron accelerates cardiovascular disease: the importance of maintaining iron balance.

• Laura D'Erasmo, Italy - Response to treatment and occurrence of cardiovascular (cv) complications in patients with autosomal recessive hypercholesterolemia (ARH): A Retrospective Analysis

• Monika Sharma, New Zealand - Calcium dependent endocytosis and recycling of lipoprotein(a) in hepg2 cells

​best poster award

• ​Barbara Kollerits, Austria - PLASMA CONCENTRATIONS OF AFAMIN ARE ASSOCIATED WITH THE  PREVALENCE AND INCIDENCE OF TYPE 2 DIABETES MELLITUS
  
• Julie Gall, France - REDUCTION IN PLASMA CHOLESTEROL EFFLUX CAPACITY FROM HUMAN MACROPHAGES IS ASSOCIATED WITH THE APPEARANCE OF CLINICAL FEATURES OF METABOLIC SYNDROME
• Jennifer J. Robinson, USA - PHARMACODYNAMIC RELATIONSHIP BETWEEN PCSK9, ALIROCUMAB, AND LDL-C LOWERING IN FOUR PHASE 3 ODYSSEY TRIALS WITH/WITHOUT STATIN BACKGROUND
  
• Stefano Manzini, Italy - HEPATIC MIRNA EXPRESSION PROFILING IN GENETICALLY MODIFIED MOUSE MODELS OF DIFFERENT ATHEROSCLEROSIS SUSCEPTIBILITY
• Laura Michael, USA - GENETIC CORRELATIONS BETWEEN CIRCULATING MIRNAS AND LIPID PROFILES REVEAL NOVEL BIOMARKERS OF CVD RISK
  
• Katrina Ellis, Australia - The prevalence of familial hyperlipidaemia and hyper-lipoprotein(a) in mutation-negative familial hypercholesterolaemia and associations with cardiovascular events
• Núria Amigó, Spain - PRO-ATHEROGENIC LIPOPROTEIN PROFILE ASSOCIATED WITH WHITE MATTER LESIONS IN CHRONIC KIDNEY DISEASE PATIENTS: A 1H-NMR METABOLOMIC APPROACH
  
• James A. Goldstein, USA - COMPOSITION OF CORONARY PLAQUES BY CT ANGIOGRAPHY: VALIDATION BY NEAR-INFRARED SPECTROSCOPY
• Calvin Yeang, USA - EXPRESSION OF E06, A NATURAL MONOCLONAL ANTIBODY TARGETED TO OXIDIZED PHOSPHOLIPIDS (OXPL), ATTENUATES THE PROGRESSION OF AORTIC SCLEROSIS IN AGED HYPERLIPIDEMIC MICE
• Gloria Balzarotti, Italy - ROLE OF PCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) IN OBESITY AND METABOLIC SYNDROME: BEYOND LDLR TARGETING
• ​Hsin-Yen Yang Yen, Taiwan - Identification of a novel apolipoprotein that facilitates MTP-mediated LIPID transport
  
• Mike Petriello, USA - PLASMA LEVELS OF THE PRO-ATHEROGENIC NUTRIENT BIOMARKER TMAO IS INCREASED BY EXPOSURE TO DIOXIN-LIKE POLLUTANTS THROUGH UPREGULATION OF FMO3
• Josefa Girona, Spain - PCSK9 CIRCULATING LEVELS AND CETP PLASMA ACTIVITY ARE ASSOCIATED INDEPENDENTLY OF LIPID LOWERING THERAPIES
  
• Hyun Kook, Republic of Korea - MDM2 E3 LIGASE-mediated ubiquitination and degradation of HDAC1 in vascular calcification
• Adrijana Kirsch, Austria - PONATINIB AUGMENTS VASOCONSTRICTION AND ATTENUATES VASORELAXATION IN MOUSE AORTIC RINGS
• Dennis Wolf, Germany - ACUTE EXPOSURE TO AIR POLLUTION AGGRAVATES ACUTE MYOCARDIAL INFARCTION AND SUBSEQUENT ISCHEMIC HEART FAILURE IN MICE​​
• Laura Michael, USA - GENETIC CORRELATIONS BETWEEN CIRCULATING miRNAs AND LIPID PROFILES REVEAL NOVEL BIOMARKERS OF CVD RISK